Rare Disease Drug Launch – Lessons Learned to Ensure Success is Not a Rare Event, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss critical areas of focus for successful rare disease product launch and explain how to build strong connections with HCPs, patients, and advocacy organizations. Attendees will learn about the new approach for access strategy in rare disease and focused planning and execution with small teams.

Xtalks Logo

Xtalks Life Science Webinars

This webinar will focus on key challenge areas and critical success factors in rare disease launch readiness including accurate opportunity sizing, engaging advocates, managing accelerated review timelines and access challenges.

Rare disease drug launches are more common than ever. Commercial teams will continue to need rare disease drug launch expertise, as over a third of industry R&D pipeline are orphan drugs. Preparing for a rare disease drug launch is more challenging than ever before with increased competition, price pressures, and customer expectations. Success in rare disease drug launch depends on early preparation, tailored strategy, and an exquisite understanding of and responsiveness to customer needs.

With a $131 billion market valuation and 11% growth rate, it’s clear why rare disease product launch has increased. Commercial attractiveness of rare disease drug launches stems from high price points, increased exclusivity and R&D tax and cost benefits. Orphan drug designation enables 7-10-year market exclusivity and an asset can hold orphan designations across several indications.

This webinar will focus on key challenge areas and critical success factors in rare disease launch readiness including accurate opportunity sizing, engaging advocates, managing accelerated review timelines and access challenges. Our industry and professional services speakers will share lessons learned from real examples of rare disease launch readiness efforts.

Join Beth Schurman, Partner, Herspiegel Consulting and Jennifer Beachell, Vice President Commercial, Momenta Pharmaceuticals in a live webinar on Friday, October 9, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Rare Disease Drug Launch – Lessons Learned to Ensure Success is Not a Rare Event.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website